10.9.20
BioTech Initiates Phase 2 Research on BIO-203 in Patients With Hemalytic Pneumogisclerosis
More
10.9.20
BioTech Releases Second Quarter 2020 Finance Report
More
10.9.20
BioTech Initiates Phase 2 Research on BIO-203 in Patients With Hemalytic Pneumogisclerosis
More
10.9.20
BioTech Releases Second Quarter 2020 Finance Report
More
10.9.20
BioTech Wins Life Science Innovation Award for Neurimeter Technology
More
10.9.20
BioTech Wins Life Science Innovation Award for Neurimeter Technology
More
10.9.20
BioTech Releases Second Quarter 2020 Finance Report
More
10.9.20
BioTech Initiates Phase 2 Research on BIO-203 in Patients With Hemalytic Pneumogisclerosis
More
10.9.20
BioTech Initiates Phase 2 Research on BIO-203 in Patients With Hemalytic Pneumogisclerosis
More
10.9.20
BioTech Releases Second Quarter 2020 Finance Report
More
10.9.20
BioTech Initiates Phase 2 Research on BIO-203 in Patients With Hemalytic Pneumogisclerosis
More
10.9.20
BioTech Releases Second Quarter 2020 Finance Report
More
10.9.20
BioTech Wins Life Science Innovation Award for Neurimeter Technology
More
10.9.20
BioTech Wins Life Science Innovation Award for Neurimeter Technology
More
10.9.20
BioTech Initiates Phase 2 Research on BIO-203 in Patients With Hemalytic Pneumogisclerosis
More
10.9.20
BioTech Releases Second Quarter 2020 Finance Report
More
10.9.20
BioTech Wins Life Science Innovation Award for Neurimeter Technology
More
10.9.20
BioTech Wins Life Science Innovation Award for Neurimeter Technology
More
10.9.20
BioTech Initiates Phase 2 Research on BIO-203 in Patients With Hemalytic Pneumogisclerosis
More
10.9.20
BioTech Releases Second Quarter 2020 Finance Report
More
10.8.20
BioTech Wins Life Science Innovation Award for Neurimeter Technology
More
10.8.20
BioTech Initiates Phase 2 Research on BIO-203 in Patients With Hemalytic Pneumogisclerosis
More
08.17.19
BioTech Releases Second Quarter 2020 Finance Report
More